For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit

News & Updates


Is Evusheld useful for MS Patients?

EVUSHELD is a medication that is FDA approved for for pre-exposure prophylaxis for prevention of coronavirus disease 2019 (COVID-19).This means this medication is taken as a precaution to protect from developing severe illness covid infection in future.It is used for patients who are immune compromised due to a medical condition or on immunosuppressive medicines who may be at risk for severe COVID 19 in infection due to weakened immune system.EVUSHELD consists of two antibody combinationsIt is...

Cortical Lesions in Multiple Sclerosis

The commonly discussed MS plaques are within the white matter (WM) of the brain and are called (WM) lesions and can be seen on regular MRIs.Interestingly, a different type of lesion has been described in the cortex of MS patients, and a significant number of MS patients has these cortical lesions.The presence of cortical MS lesions has been confirmed in several pathological and imaging studies and has been recognized as an important component of MS.Despite resembling areas of WM demyelination,...

Two New Clinical Trials currently enrolling patients at the MS center

A randomized study comparing the effectiveness and impact of Telemedicine in addition to standard care versus standard care alone to manage tolerability, adherence and related patient reported outcomes in patients with relapsing forms of multiple sclerosis newly treated with diroximel fumarate (Vumerity®)Description: This study aims to understand the effectiveness and impact of telemedicine compared to standard care over the course of 12 months. Participants will have relapsing forms of MS and...

Weill Cornell Medicine Multiple Sclerosis Center 1305 York Ave., Second Floor New York, NY 10021